{"id":"polidocanol-injectable-foam-0-5","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Pain"},{"rate":"5-10%","effect":"Swelling"},{"rate":"5-10%","effect":"Bruising"},{"rate":"1-5%","effect":"Numbness"},{"rate":"1-5%","effect":"Itching"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This leads to the formation of a thrombus, which eventually closes off the vein, preventing further blood flow and alleviating symptoms of varicose veins. The exact mechanism is not fully understood, but it is thought to involve the activation of various cellular pathways and the release of pro-inflammatory mediators.","oneSentence":"Polidocanol works by causing endothelial damage and subsequent thrombosis in the targeted vein.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:29:30.775Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of varicose veins and telangiectasias"}]},"trialDetails":[{"nctId":"NCT01072877","phase":"PHASE3","title":"Efficacy and Safety Study of Polidocanol Injectable Foam for the Treatment of Saphenofemoral Junction (SFJ) Incompetence","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2010-12","conditions":"Varicose Veins","enrollment":279},{"nctId":"NCT01231373","phase":"PHASE3","title":"Polidocanol Endovenous Microfoam (PEM) Versus Vehicle for the Treatment of Saphenofemoral Junction (SFJ) Incompetence","status":"COMPLETED","sponsor":"Boston Scientific Corporation","startDate":"2010-11","conditions":"Varicose Veins","enrollment":235}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"polidocanol injectable foam, 0.5%","genericName":"polidocanol injectable foam, 0.5%","companyName":"Boston Scientific Corporation","companyId":"boston-scientific-corporation","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Polidocanol works by causing endothelial damage and subsequent thrombosis in the targeted vein. Used for Treatment of varicose veins and telangiectasias.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}